CClinicalTrials.gg
CompletedNCT04532008ASHAUpdated Aug 31, 2020

Depression Treatment and Economic Empowerment

An interventional study of Group based treatment in Depressive Symptoms, sponsored by Albert Einstein College of Medicine. Completed. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2020-08-31.

Sponsored by Albert Einstein College of Medicine · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 years 11 months after the study started (first participant enrolled Sep 2012, registered Aug 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

This pilot study randomized 48 depressed rural Bangladeshi housewives to either intervention or control groups. The intervention groups received depression treatment and a financial empowerment intervention.

Read the detailed description

This study was conducted in the rural Sirajganj region of Bangladesh. Working with the International Centre for Diarrhoeal Disease Research, Bangladesh and a local NGO, we recruited 48 depressed rural housewives for the study. Participants were randomized into intervention in control groups. The intervention groups (n=24) received 12 sessions of evidence based depression treatment, financial literacy education, agricultural training and skill building. They opened bank accounts and saved for six months. At the end of the six month period, participants who had met savings and attendance requirements received a cash transfer of approximately $186, which was used to purchase a productive asset. 22 participants purchased an agricultural animal, usually a goat; 1 financed a small retail business, and 1 leased land to grow crops for sale. Depression scores on the PHD-9 were sharply reduced. The study had 100% retention.

02

Conditions studied

  • Depressive Symptoms

Browse trials for

03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 48 is below the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Albert Einstein College of Medicine is the lead sponsor of 199 studies on the registry; 21 are open to participants now.

Of its 44 completed or terminated interventional studies of FDA-regulated products, 35 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18-40
  • PHQ greater than 10
  • Able to save
  • Able to read and write

Exclusion criteria

Exclusion Criteria:

  • Not in age range PhQ below 10 Unable to contribute to savings account Illiterate
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (actual)

Study arms

  • No intervention
    Control Group

    No intervention

  • Experimental
    Treatment Group

    Experimental group received 12 session of group based depression treatment, a matched savings program, financial literacy training, agricultural training, and a cash transfer.

    Behavioral: Group based treatment

Interventions

  • BehavioralGroup based treatment

    12 sessions of group based therapy that included cognitive restructuring, behavioral activation, and interpersonal therapy

06

What researchers measure

Primary outcomes

  1. Depressive Symptoms

    symptoms on the Patient Health Questionnaire (PHD-9), ranging from 0 to 27, with higher scores indicating worse outcomes

    Time frame: 12 months post baseline

Secondary outcomes

  1. Retention

    Percentage of participants in the intervention group completing the intervention

    Time frame: Assessed at 12 Months post basline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04532008
Lead sponsor
Albert Einstein College of Medicine
Collaborators
International Centre for Diarrhoeal Disease Research, Bangladesh
Responsible party
Alison Karasz (Associate Professor, Albert Einstein College of Medicine) — Principal investigator
First posted
Aug 31, 2020
Start date
Sep 1, 2012
Primary completion
Sep 1, 2014
Completion
Aug 15, 2020
Last update
Aug 31, 2020

Study contacts

Alison Karasz
principal investigator · Albert Einstein College of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion